Most dogs diagnosed with hemangiosarcoma will die within one to two weeks without treatment. That number comes from the University of Minnesota’s veterinary cancer center, and it reflects the aggressive nature of this blood vessel cancer. However, the timeline varies significantly depending on where the tumor is located. A dog with a skin-surface tumor may live months, while a dog with a tumor on the heart may have only days.
A large UK study of 788 dogs clinically diagnosed with hemangiosarcoma found an overall median survival of just 9 days across all cases and locations. Only 12% of those dogs were still alive one year later. These numbers include dogs who received some form of treatment, which means the untreated outlook is even shorter for most internal tumors.
Why Location Changes Everything
Hemangiosarcoma grows from the cells lining blood vessels, so it can appear almost anywhere in the body. But where it shows up determines how fast it kills. The four most common locations are the spleen, heart, liver, and skin, and each carries a very different prognosis.
Spleen: This is the most common site. Splenic tumors grow silently inside the abdomen and often aren’t detected until they rupture and cause internal bleeding. In the UK study, dogs with a clinical diagnosis of splenic hemangiosarcoma had a median survival of 80 days (just under three months), though that figure includes dogs who had surgery. Without any treatment, the timeline collapses to days or a few weeks. Even surgery alone, without chemotherapy, is considered palliative, buying an average of about two months before the cancer spreads to the lungs or causes bleeding in other abdominal organs.
Heart: Tumors on the heart, typically the right atrium, are among the most dangerous. They can cause fluid to build up around the heart, leading to sudden collapse. The median survival in the UK study was effectively 0 days for cardiac cases, meaning more than half of dogs died or were euthanized the same day they were diagnosed. The one-year survival rate was just 3%.
Liver: Hepatic hemangiosarcoma carries a similarly grim prognosis. Median survival in the UK study was also 0 days at clinical diagnosis, with a one-year survival rate under 4%. When dogs with liver tumors did receive treatment, median survival extended to 79 days.
Skin: Cutaneous hemangiosarcoma is the one form where longer survival is realistic. If the tumor is confined to the skin surface, it may be treated successfully with surgery alone. The UK study found a median survival of 119 to 248 days for skin tumors (roughly 4 to 8 months), depending on diagnostic criteria, and a one-year survival rate as high as 43%. The catch: if the tumor extends deeper into the muscle layer, it behaves just as aggressively as the internal forms.
What Happens When the Tumor Ruptures
The reason untreated hemangiosarcoma kills so quickly is that these tumors are essentially fragile, blood-filled sacs. They grow rapidly, and their walls are weak. When a tumor ruptures, blood pours into the abdomen (for splenic and liver tumors) or into the sac around the heart (for cardiac tumors).
The classic scenario is painfully sudden. A seemingly healthy older dog, often a large breed like a Golden Retriever or German Shepherd, is fine in the morning. By the time their family comes home, the dog is weak, pale, panting, or collapsed. An emergency vet visit typically reveals free blood in the abdomen from a ruptured splenic tumor. Some dogs stabilize temporarily as their body reabsorbs the blood, only to rupture again days or weeks later. Each bleeding episode is life-threatening, and without intervention, one of them will be fatal.
The Role of Breed and Stage
Certain breeds are dramatically overrepresented. Golden Retrievers, German Shepherds, Labrador Retrievers, and Portuguese Water Dogs face higher risk. The cancer typically appears in middle-aged to older dogs, usually between 8 and 13 years old. By the time symptoms appear, the disease has often already spread. Hemangiosarcoma is notorious for early, invisible metastasis. Even when the primary tumor looks localized on imaging, microscopic cancer cells have frequently seeded to the lungs, liver, or other organs.
This is why the numbers look so stark even with treatment. Among dogs in the UK study who had a confirmed tissue diagnosis (meaning they survived long enough for a biopsy or surgery), median survival was 105 days, roughly three and a half months. The one-year survival rate for that group was 28%. Those are the dogs who got care. Without it, the window is far narrower.
What “No Treatment” Actually Looks Like
Choosing not to pursue surgery or chemotherapy doesn’t mean doing nothing. Many families opt for comfort-focused care: keeping their dog pain-free, maintaining appetite and quality of life, and watching closely for signs of internal bleeding. This approach is a valid choice, especially for very old dogs, dogs with other serious health conditions, or families facing financial constraints.
In practical terms, a dog with untreated visceral hemangiosarcoma may have a handful of good days to a few good weeks before a bleeding crisis. Some dogs experience a brief, partial recovery after a small bleed as the body reabsorbs the blood, creating a window where they seem almost normal. These windows can be meaningful time, but they’re unpredictable and get shorter with each episode.
For skin-based tumors that haven’t invaded deeper tissue, the timeline without treatment is more forgiving. The tumor may grow slowly enough that a dog remains comfortable for weeks to months, though it will eventually ulcerate, bleed, or spread internally.
How Treatment Changes the Timeline
Treatment doesn’t cure hemangiosarcoma in most cases, but it can meaningfully extend survival. For splenic tumors, removing the spleen buys about two months on average. Adding chemotherapy after surgery pushes median survival to roughly four to six months, with some dogs reaching a year. For cardiac tumors, surgical options are more limited, and even with treatment, survival is measured in weeks to a few months.
The honest reality is that hemangiosarcoma remains one of the most aggressive cancers in veterinary medicine. Whether a family chooses treatment or comfort care, the focus shifts to quality of the remaining time rather than a cure. Knowing the typical timelines helps you make the decision that’s right for your dog and your family, with a clear picture of what to expect.